Activating c-KIT mutations confer oncogenic cooperativity and rescue RUNX1/ETO-induced DNA damage and apoptosis in human primary CD34+ hematopoietic progenitors-Reference-Cited by-同舟云学术

Activating c-KIT mutations confer oncogenic cooperativity and rescue RUNX1/ETO-induced DNA damage and apoptosis in human primary CD34+ hematopoietic progenitors

Published:2014-06-04 Issue:2 Volume:29 Page:279-289
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Wichmann C,Quagliano-Lo Coco I,Yildiz Ö,Chen-Wichmann L,Weber H,Syzonenko T,Döring C,Brendel C,Ponnusamy K,Kinner A,Brandts C,Henschler R,Grez M

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2014179.pdf

Reference53 articles.

1. Yan M, Burel SA, Peterson LF, Kanbe E, Iwasaki H, Boyapati A et al. Deletion of an AML1-ETO C-terminal NcoR/SMRT-interacting region strongly induces leukemia development. Proc Natl Acad Sci USA 2004; 101: 17186–17191.

2. Wildonger J, Mann RS . The t(8;21) translocation converts AML1 into a constitutive transcriptional repressor. Development 2005; 132: 2263–2272.

3. Ptasinska A, Assi SA, Mannari D, James SR, Williamson D, Dunne J et al. Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding. Leukemia 2012; 26: 1829–1841.

4. Song J, Mercer D, Hu X, Liu H, Li MM . Common leukemia- and lymphoma-associated genetic aberrations in healthy individuals. J Mol Diagn 2011; 13: 213–219.

5. Mulloy JC, Cammenga J, Berguido FJ, Wu K, Zhou P, Comenzo RL et al. Maintaining the self-renewal and differentiation potential of human CD34+ hematopoietic cells using a single genetic element. Blood 2003; 102: 4369–4376.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering an inducible leukemia-associated fusion protein enables large-scale ex vivo production of functional human phagocytes;Proceedings of the National Academy of Sciences;2024-06-10

2. Pediatric acute myeloid leukemia with t(8;21) and KIT mutation treatment with avapritinib post-stem cell transplantation: a report of four cases;Annals of Hematology;2024-05-28

3. Pediatric acute myeloid leukemia with t(8;21) and KIT mutation treatment with avapritinib post-stem cell transplantation: a case report;2024-01-16

4. Deciphering Acute Myeloid Leukemia Associated Transcription Factors in Human Primary CD34+ Hematopoietic Stem/Progenitor Cells;Cells;2023-12-29

5. Combination of eriocalyxin B and homoharringtonine exerts synergistic anti-tumor effects against t(8;21) AML;Acta Pharmacologica Sinica;2023-11-28